Home/Filings/4/0001250853-14-000029
4//SEC Filing

Galena Biopharma, Inc. 4

Accession 0001250853-14-000029

$SLSCIK 0001390478operating

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 9:35 PM ET

Size

4.9 KB

Accession

0001250853-14-000029

Insider Transaction Report

Form 4
Period: 2013-12-31
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
  • Other

    Common Stock

    2013-12-31$1.88/sh+5,656$10,625509,665 total
Footnotes (1)
  • [F1]Pursuant to the Issuer's Employee Stock Purchase Plan.

Issuer

Galena Biopharma, Inc.

CIK 0001390478

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001390478

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 9:35 PM ET
Size
4.9 KB